We examined the risk of bacteremia in patients with liver cirrhosis (compared with the risk for all Danish citizens 120 years of age who were living in North Jutland County, Denmark), as well as the type of bacteremia and the 30-day case-fatality rate. We used the Danish National Registry of Patients to identify 1339 patients with liver cirrhosis, and we used the North Jutland County Bacteremia Database to identify episodes of bacteremia. We observed 117 cases of bacteremia in patients with liver cirrhosis (11.0 cases were expected), which yielded a standardized incidence ratio of 10.5 (95% confidence interval [CI], 8.8-12.7). Sixty-two cases of bacteremia were nosocomial infections. There were 53 cases of gram-positive bacteremia, 55 cases of gram-negative bacteremia, and 8 cases of polymicrobial bacteremia (1 case of candidemia was excluded from the analysis). The most common cause of death was bleeding from gastroesophageal varices; the second most common cause of death was infection in the respiratory system. The 30-day case-fatality rate was 0.53 (95% CI, 0.39-0.73). Patients with liver cirrhosis had an increased risk of bacteremia and a poor prognosis.
Patients with liver cirrhosis often have serious infections [1, 2] . The immunologic reasons for increased risk may include multifactorial impairment of the immune system, which includes changes in humoral immunity with decreased synthesis in the complement system (which is part of the defense mechanism against infections caused by gram-negative organisms). Patients with liver cirrhosis may have disruption of the intestinal mucosa because of edema [3] ; therefore, hepatic filtration of bacteria may be bypassed in patients with portal hypertension [4] . Patients with liver cirrhosis also have a lower number of Kupffer's cells, and alteration in cellular immunity leads to a decrease in the number of neutrophils and impairment of their function [5] . An study which used animals has suggested decreased defense against Streptococcus pneumoniae in patients with decompensated liver cirrhosis [6] .
It has been hypothesized that rupture of natural barriers induced by invasive diagnostic or therapeutic procedures may be involved in the pathogenesis of infections [7] . The existing studies have been based mainly on single-center analyses [8, 9] or on data for patients who had primarily been included in randomized trials of therapeutic prophylactic antibiotic therapy [10] . Thus, few studies have systematically examined the risk and outcome of bacteremia in a clinical epidemiological design.
On the basis of this background information, we conducted a 15-year population-based study in northern Denmark. We estimated the standardized incidence ratio (SIR) for bacteremia among patients with liver cirrhosis, examined the type of bacteremia, evaluated the death certificates of the patients who died from bacteremia, and estimated the 30-day case-fatality rate.
Patients and Methods
The study was conducted in North Jutland County, Denmark, which has ∼490,000 inhabitants and which represents 9% of the total Danish population. Shortly after birth, all Danish citizens are assigned a unique personal identification number (CPR number), which includes the person's sex and date of birth.
Identification of patients with liver cirrhosis. The cohort of patients with liver cirrhosis in North Jutland County was identified for the period from January 1977 through December 1993. Patients with liver cirrhosis were identified through the Danish National Registry of Patients, which includes 99.1% of all patients discharged from hospitals in Denmark since 1977 [11] . Each discharge record includes the patient's CPR number, date of admission, date of discharge, and up to 20 discharge diagnoses. Diagnoses were classified according to the Danish version of the International Classification of Diseases, 8th Edition (ICD-8) [12] .
The study cohort was stratified into 2 subcohorts according to whether alcohol was considered the etiological factor for liver cirrhosis. One subcohort of patients was discharged with a diagnosis of alcoholic liver cirrhosis (ICD-8 571.09), and the other was discharged with a diagnosis of nonalcoholic liver cirrhosis. The latter group consisted of patients with nonalcoholic liver cirrhosis (ICD-8 571.99), primary biliary cirrhosis (ICD-8 571.90), nonspecified cirrhosis (ICD-8 571.92), chronic hepatitis (ICD-8 571.93), and other types of cirrhosis in which alcoholism was not indicated (ICD-8 571.99). To reduce misclassification, patients for whom both a diagnosis of alcoholism (ICD-8 303) and any type of cirrhosis (other than alcoholic liver cirrhosis) was recorded from 1977 through 1993 were included in the subcohort of patients with alcoholic liver cirrhosis.
We excluded patients younger than 20 years from the cohort because children often have inborn errors of metabolism or malformations as the etiological factor for liver cirrhosis. Furthermore, the pattern and prognosis of bacteremia during childhood are different than the pattern and prognosis during adulthood.
Identification of cases with bacteremia. All cultures of blood specimens obtained in North Jutland County were processed by the Department of Clinical Microbiology, Aalborg Hospital. A total of 8067 episodes of bacteremia were registered in the North Jutland County Bacteremia Database during the study period, and the total number of patients who had an episode of bacteremia was 7033. The following variables were registered for each individual record: CPR number, date of venipuncture for positive blood cultures, bacterial or fungal species, a note if the positive result of blood culture was nosocomial, pattern of antibiotic susceptibilities, and the patient's name. Because previous reports evaluated positive results of blood cultures and found that not all were valid [13] , all information was evaluated by a clinical microbiologist before being entered into the database to avoid registration of contaminated blood cultures. Cases of nosocomial bacteremia were defined as episodes of bacteremia acquired in hospitals, or acquired by patients who were in frequent contact with the hospital (such as those receiving chemotherapy or undergoing dialysis), or acquired by patients who were discharged from the hospital 30 days before this hospital admission [14] . Community-acquired bacteremia was defined as an episode of bacteremia present at admission to the hospital (i.e., positive results of cultures of blood specimens obtained within the first 48 hours of hospitalization). The database contains information on all episodes of bacteremia in North Jutland County since 1981. The follow-up period for bacteremia was from January 1981 until the end of December 1995. The cases of bacteremia were identified by linking all records of the study cohort that were obtained in the Danish National Registry of Patients via the CPR number to the North Jutland County Bacteremia Database.
Determination of the 30-day case-fatality rate. We obtained information regarding vital statuses from the Civil Registration System, which includes a person's date of emigration, date of transfer to another Danish county, and date of death. The Civil Registration System has kept a record of all changes in vital statistics since 1968. Information on the causes of death was obtained from the National Registry of Deaths, which contains information on all death certificates dating back to 1943 [15] . We examined the causes of deaths for all patients with liver cirrhosis who had died within 30 days of diagnosis of bacteremia.
Statistical analysis. The duration of follow-up time was calculated from the time period beginning with the date 1 January 1981 or the patient's earliest discharge date with liver cirrhosis, whichever came first, until the first episode of bacteremia, death, emigration, or the end of the study period (31 December 1995). Thus, only the initial episode of bacteremia was included in the study.
The incidence rate of bacteremia among the background population (all Danish citizens older than 20 years who were living in North Jutland County) was calculated in sex-specific groups, 20-year age groups and 5-year calendar periods. The reason for calculating the different incidence rates was that the incidence may change with age and sex and over calendar time. We reported the summarized incidence rate for calendar time, since the strata of calendar time had only a small variation. Multiplication of personyears under observation by incidence rates in each category yielded the number of cases of bacteremia expected if patients with liver cirrhosis had the same risk of bacteremia as did the county's background population. The SIRs (i.e., the ratios of observed-to-expected cases of bacteremia) yielding a relative measurement were calculated, and 95% CIs were computed under the assumption that the observed number of cases in a specific category follows a Poisson distribution. Exact limits were used when the observed number was !10 [16] .
We used logistic regression analysis to estimate the association between bacteremia and the 30-day case-fatality rate (deaths occurring within 30 days after a positive blood culture result was obtained). In the model, the cohort was divided according to type of liver cirrhosis (i.e., alcoholic or nonalcoholic [the reference group]) and according to type of bacteremia (gram-positive [the reference group], gram-negative, or polymicrobial episodes). One episode of candidemia was excluded from the analysis. The origin of bacteremia was classified as community-acquired (the reference group) or nosocomial. The cohort was divided into 3 age categories: 20-39 years (the reference group), 40-59 years, and у60 years. The cohort was divided according to sex, with women as the reference group.
Results
During the study period, we identified 1339 patients with liver cirrhosis, of whom 59% were men and 41% were women. In the study cohort, 54% of patients had alcoholic liver cirrhosis (70% of men and 30% of women), and 46% had nonalcoholic liver cirrhosis (46% of men and 54% of women). The mean age of the patients at study entry was 58.1 years, and the mean follow-up was 4.8 years (table 1) .
We found 117 first-time episodes of bacteremia during the study period, 70 of which occurred in patients with alcoholic liver cirrhosis and 47 occurred in patients with nonalcoholic liver cirrhosis. The incidence rate of bacteremia among patients with liver cirrhosis was 18.3 per 1000 person-years (95% CI, 15.1-21.9). Compared with the background population, the subcohort of patients with alcoholic liver cirrhosis had a risk of bacteremia with an SIR of 13.9 (95% CI, 10.8-17.6). The SIR decreased with increasing age (table 2) .
Of the 117 patients with bacteremia, 62 had nosocomial infection. We found 53 cases of gram-positive bacteremia. Staphylococcus aureus accounted for 26 of the 53 cases of gram-pos- (table 3) .
Of the 117 patients with bacteremia, 62 died within 30 days of diagnosis. Of the 62 patients who died, 37 had nosocomial infection. The most common cause of death was bleeding from gastroesophageal varices (21%); this was followed by infection in the respiratory system (15%), including pneumonia; heart failure and myocardial infarction (10%); endocarditis (6%); meningitis (6%); other infections (8%); and malignant disease (3%). Furthermore, a few patients died of kidney failure and other complications of liver cirrhosis.
The 30-day case-fatality rate was 0.53 (95% CI, 0.39-0.73) among patients with liver cirrhosis, whereas the 30-day casefatality rate among the 6424 other patients older than 20 years who had their first episode of bacteremia was 0.27 (95% CI, 0.26-0.29), resulting in a ratio of case-fatality rates of 1.9:1 (95% CI, 1.4-2.4). The mean age of the patients with liver cirrhosis and bacteremia was 58.1 years; 58% were men, and 60% had alcoholic liver cirrhosis. When examining factors associated with 30-day case fatality, we used logistic regression models. Patients with liver cirrhosis who were older than 60 years tended to have a better, although nonsignificant, prognosis than did patients younger than 40 years. The 30-day casefatality rate was higher among men (adjusted OR, 3.4; 95% CI, 1.5-7.9) than among women. The type of bacteremia did not affect the risk of death: gram-negative bacteremia was associated with an adjusted OR of 1.3 (95% CI, 0.5-2.8), and polymicrobial bacteremia was associated with an adjusted OR of 1.1 (95% CI, 0.2-5.6). Nosocomial infection was associated with a higher risk of 30-day case fatality (adjusted OR, 1.7; 95% CI, 0.7-3.5) than was community-acquired infection (table 4).
Discussion
We found that, compared with the background population, patients with liver cirrhosis have a considerably increased risk of bacteremia. More than half of the bacteremic episodes were nosocomial, and E. coli was the most common etiologic agent of bacteremia. The short-term prognosis was poor; it seemed to be less dependent of the type of bacteremia than on age, sex, and nosocomial infection.
Our study design had strengths and limitations. Compared with single-center studies, we had a large sample, and our study was based on a uniformly organized health care system with a primary catchment area. Following a longitudinal populationbased design, we had complete follow-up. It is well known that discharge diagnoses may vary in quality [17] , but a previous validation study has shown that the diagnoses of liver cirrhosis in the hospital discharge registry are of high quality [18] . The validity of data in the bacteremia database has previously been evaluated and was also of high quality [19] . The weaknesses of the diagnoses include lack of clinical details, especially information about alcohol consumption and the degree of liver cirrhosis. Alcoholic patients and patients with cirrhosis of the liver seem to have an increased risk of complications, including infections [20] [21] [22] . Data for our study were collected from different independent sources, which actually might have been a strength, since the study itself did not affect the diagnostic process and thus did not introduce bias resulting from surveillance, as is seen in prospective follow-up studies.
Patients with liver cirrhosis have impaired immunity that may lead to an increased risk for a number of infections. Our study supports previous studies of patients with liver cirrhosis that showed an increased risk of bacteremia [9, 23, 24] . We did not find as many cases of gram-negative bacteremia as a previous study found [24] ; however, we did find a higher proportion of these cases than did other studies [8, 25] . In one study, the study population consisted mostly of patients with hepatitis as the etiologic cause of liver cirrhosis [24] , whereas other study cohorts included a higher proportion of patients with alcoholic liver cirrhosis [8, 25] . We found a higher frequency of bacteremia with S. aureus than was noted in one study [26] , but a slightly lower frequency of community-acquired infections among hospitalized patients with liver cirrhosis than in another large study [27] .
The estimated incidence proportion of bacteremia was 8% during a 5-year period in a study of 197 patients with cirrhosis of the liver [24] , and there were no differences in risk of infection between alcoholic liver cirrhosis and other types of cirrhosis. In a previous Danish study [23] , the annual incidence proportion of bacteremia was estimated at 4.5%, and in a 5-year study of 1623 admissions with liver cirrhosis [8] , there were 57 cases of bacteremia (of which 70% were gram-negative infections; incidence proportion, 3.5%). In another Danish study [9] , 43 patients who had liver cirrhosis and 1 episode of bacteremia were compared with 43 patients with liver cirrhosis who did not have bacteremia; the authors of the study concluded that bacteremia was a serious prognostic sign, mostly because of the late occurrence in patients with liver cirrhosis. In our study, we used person-years of follow-up in the risk estimates, which provide a more valid estimate of the increased risk of bacteremia. An episode of gram-negative bacteremia was not a strong predictor of higher 30-day case-fatality rates among patients with liver cirrhosis who had an episode of bacteremia.
Cirrhotic patients with gastrointestinal bleeding have a better prognosis when they are treated with antibiotic prophylaxis [28] . It has been suggested that liver cirrhosis may cause fever [29] , but on the other hand, patients with liver cirrhosis may not develop fever during serious infections or neck stiffness during meningitis [30] . Blood cultures should probably be performed as soon as a patient shows a slight sign of fever, and thus early treatment could be implemented. However, on the basis of existing data, it remains unclear whether early diagnosis and treatment may improve outcomes for patients.
In conclusion, our results strongly support the fact that patients with liver cirrhosis are at increased risk of bacteremia and that the prognosis is poor compared with patients without liver cirrhosis who have bacteremia.
